Miles Congreve BSc, PhD

Dr Congreve has an excellent track record in drug discovery and development in both big pharma and biotechnology settings. He began his career with Glaxo in 1993 and worked on a range of GPCR, other receptor and enzyme projects both in lead optimisation and hit-to-lead phases, a number of which led successfully to clinical candidates. He later moved to manage the Glaxo Wellcome Chemistry Laboratory in Cambridge, working on solid phase library technologies and initiating a number of collaborations with academics across the UK.

Dr Congreve joins Heptares from Astex Therapeutics where he was Director of Chemistry. He played a critical role in establishing the team which developed and validated fragment-based drug discovery as a new approach to structure-based drug design and lead identification. The platform delivered five preclinical and clinical candidates in collaborative and in-house projects.

Dr Congreve obtained a BSc in Biological Chemistry from Leicester University and a PhD in Synthetic Chemistry from Cambridge University. He is co-author of more than 50 publications and co-inventor on more than 30 patent filings.